MDGL Operating Cash Flow (Statement)
Madrigal Pharmaceuticals Inc · Operating Cash Flow (Statement)
MDGL Operating Cash Flow (Statement)
Latest reported$23.33Mperiod ending
MDGL Quarterly Cash from Operations (-$13.37M → $23.33M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
MDGL operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 23,329,000 | |
| -167,435,000 | |
| -133,460,000 | |
| 79,850,000 | |
| -47,052,000 | |
| -88,891,000 | |
| -104,486,000 | |
| -66,984,000 | |
| -134,945,000 | |
| -149,157,000 | |
| -79,933,000 | |
| -84,920,000 | |
| -75,310,000 | |
| -84,067,000 | |
| -58,515,000 | |
| -59,069,000 | |
| -57,360,000 | |
| -49,913,000 | |
| -48,051,000 | |
| -45,556,000 | |
| -46,881,000 | |
| -43,429,000 | |
| -54,947,000 | |
| -47,850,000 | |
| -24,258,000 | |
| -30,506,000 | |
| -12,282,000 | |
| -11,324,000 | |
| -11,540,000 | |
| -6,478,000 | |
| -6,265,000 | |
| -5,238,000 | |
| -5,360,000 | |
| -8,644,000 | |
| -5,945,000 | |
| -4,951,000 | |
| -7,650,000 | |
| -3,771,000 | |
| -5,280,033 | |
| 6,956,413 | |
| -7,070,000 | |
| -12,214,000 | |
| -19,337,000 | |
| -15,602,000 | |
| -17,730,000 | |
| -18,775,000 | |
| -19,215,000 | |
| -18,566,000 | |
| -20,874,000 | |
| -20,270,000 | |
| -18,690,000 | |
| -16,588,000 | |
| -19,919,000 | |
| -22,214,000 | |
| -12,523,000 | |
| -13,263,000 | |
| -13,095,000 | |
| -15,254,000 | |
| -10,486,000 | |
| -11,821,000 | |
| -12,154,000 | |
| -12,839,000 | |
| -8,212,000 | |
| -8,425,000 | |
| -8,973,000 | |
| -12,589,000 | |
| -7,265,000 | |
| -8,250,000 | |
| -23,521,000 | |
| 12,226,000 | |
| 16,552,000 | |
| -19,830,000 | |
| -18,941,000 | |
| -15,720,000 | |
| 68,373,000 | |
| -15,406,000 | |
| -12,567,000 | |
| -13,178,000 | |
| -11,016,000 | |
| -13,367,000 |